Ohki et al., in a study of ALL patients without known major risk-stratifying cytogenetic abnormalities, identified 17 patients with MEF2D fusion [98]; among the 15 patients for whom data were available, 8 had relapse and died from the disease [98]. The gene discussed is MEF2D; the disease is acute lymphoblastic leukemia.